| Hydroxyurea studied in …STUDIED_INderived65 of 65show fewer |
|---|
| → studied in | NCT06871410Phase 1 · recruiting Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · 65 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07507760Phase 2 · recruiting Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06930352Phase 2 · recruiting Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy · 65 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07170592Phase 1 · not yet recruiting A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07190833Phase 1 · recruiting A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea) · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05853458Phase 4 · terminated Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors · 65 trials list this drug (9 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07033598Phase 2 · recruiting Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04217356active not recruiting Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis · 65 trials list this drug (9 active) | — | — | Bone Marrow Neoplasm,Malignant Bone Marrow Neoplasm,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06093672Phase 3 · recruiting Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera · 65 trials list this drug (9 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06063317Phase 1 · terminated A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) · 65 trials list this drug (9 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05526924Phase 1 · recruiting Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | Head and Neck Neoplasm,Malignant Head and Neck Neoplasm,Head and Neck Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860844Phase 2 · terminated Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia · 65 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03107182Phase 2 · completed Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | Head and Neck Squamous Cell Carcinoma,Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02258659Phase 2 · completed Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer · 65 trials list this drug (9 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05005182Phase 2 · terminated Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts · 65 trials list this drug (9 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01847326Phase 1 · completed Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01693718Phase 2 · completed A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002868Phase 3 · completed Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711541Phase 1/Phase 2 · completed Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | Head and Neck Squamous Cell Carcinoma,Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02088541Phase 2 · completed Selinexor (KPT-330) in Older Patients With Relapsed AML · 65 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01387763Phase 3 · completed A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms · 65 trials list this drug (9 active) | — | — | Essential Thrombocythemia,Polycythemia Vera,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02214407Phase 3 · completed Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML · 65 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02899169Phase 3 · unknown Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) · 65 trials list this drug (9 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006119Phase 2 · completed Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03463733Phase 1 · unknown Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) · 65 trials list this drug (9 active) | — | — | Glioblastoma,Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00468169Phase 2 · completed Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01964755Phase 2 · terminated Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01259856Phase 3 · completed Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019474Phase 2 · completed Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer · 65 trials list this drug (9 active) | — | — | Malignant Gastric Neoplasm,Malignant Pancreatic Neoplasm,Digestive System Neuroendocrine Tumor G1+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03515018Phase 3 · unknown Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML Patients · 65 trials list this drug (9 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055874Phase 3 · completed Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117572Phase 3 · completed Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) · 65 trials list this drug (9 active) | — | — | Paranasal Sinus Neoplasm,Malignant Laryngeal Neoplasm,Malignant Nasal Cavity Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462735Phase 2 · completed Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | Malignant Head and Neck Neoplasm,Paranasal Sinus Neoplasm,Malignant Laryngeal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01632904Phase 3 · completed Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study · 65 trials list this drug (9 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00978146Phase 2 · withdrawn Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors · 65 trials list this drug (9 active) | — | — | Fibromatosis,Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00706810Phase 2 · completed Combination of Hydroxyurea and Verapamil for Refractory Meningiomas · 65 trials list this drug (9 active) | — | — | Malignant Neoplasm,Meningioma,Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01949805Phase 3 · completed Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera · 65 trials list this drug (9 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004933Phase 3 · terminated Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003590Phase 2 · completed S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma · 65 trials list this drug (9 active) | — | — | Adult Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387933Phase 1 · completed Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02480608Phase 1/Phase 2 · completed Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004) · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019058Phase 1 · completed Radiation Therapy in Treating Patients With Glioblastoma · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004094Phase 2 · unknown Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx · 65 trials list this drug (9 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002869Phase 3 · unknown Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005823Phase 3 · completed Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · 65 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025402Phase 3 · unknown Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002887Phase 1 · unknown Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer · 65 trials list this drug (9 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002951Phase 2 · completed Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00904735Phase 2 · unknown Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002771Phase 3 · unknown Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083187Phase 2 · completed VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia · 65 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004089Phase 2 · completed Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer · 65 trials list this drug (9 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004901Phase 1/Phase 2 · completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer · 65 trials list this drug (9 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003172Phase 2 · completed Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer · 65 trials list this drug (9 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023959Phase 1 · completed Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer · 65 trials list this drug (9 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354913Phase 2 · completed Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma · 65 trials list this drug (9 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002940Phase 2 · completed Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS · 65 trials list this drug (9 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01521299Phase 1 · withdrawn A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors · 65 trials list this drug (9 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01645124Phase 3 · terminated Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV) · 65 trials list this drug (9 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004897Phase 2 · terminated Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer · 65 trials list this drug (9 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290771Phase 2 · terminated Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM) · 65 trials list this drug (9 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00154375Phase 3 · completed Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma · 65 trials list this drug (9 active) | — | — | Glioblastoma,Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002674Phase 2 · completed Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia · 65 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008047Phase 1/Phase 2 · unknown Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus · 65 trials list this drug (9 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00180973Phase 3 · unknown PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE. · 65 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |